Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abramson Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9319
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abramson Cancer Center (Abramson) formerly Penn Medicine’s Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrative medicine and wellness, nutritional counseling, pastoral care, patient education and psychological counselling. It offers cancer treatments such as bone marrow and stem cell transplantation, chemotherapy, clinical trials, hormone therapy, immunotherapy, integrative medicine and wellness, managing treatment side effects, photodynamic therapy, proton therapy, radiation treatment, surgery, targeted therapy,vaccine therapy. Abramson treats for bladder cancer, breast cancer, kidney cancer, lung cancer, ovarian cancer, thyroid cancer, among others. The centre pathologists perform specialized techniques including immunohistochemical analyses, electron microscopy and molecular studies. Its centre offers services in various hospital locations across the US. Abramson Cancer Center is headquartered in Philadelphia, Pennsylvania, the US.

Abramson Cancer Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center – Key Competitors 13
Abramson Cancer Center – Key Employees 14
Abramson Cancer Center – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Oct 03, 2018: Patient death following CAR-T therapy highlights serious manufacturing issues 16
Sep 07, 2018: Penn Medicine Researchers Receive “Big Data” Grant from NIH to Test New Approach for Personalized Breast Cancer Treatments 18
Nov 01, 2017: CVS Health Foundation Awards $1 Million Dollars in Grants to Eight Cancer Centers to Increase Smoking Cessation Resources in the Oncology Setting 19
May 04, 2017: New $21 Million Gift Puts Basser Center for BRCA at the Forefront of Advancements for Patients at Risk of Inherited Cancers 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Abramson Cancer Center, Pharmaceuticals & Healthcare, Key Facts 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center, Key Competitors 13
Abramson Cancer Center, Key Employees 14
Abramson Cancer Center, Other Locations 15

List of Figures
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Phytel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality …
  • SkinMedica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SkinMedica Inc (SkinMedica), a subsidiary of Allergan Plc, is a skin care service provider. The company offers cleanse, correct, moisturize and hydrate, protect, brighten, targeted treatments and professional peels among others. It provides essential serum, rejuvenating hydrator, total defen …
  • CA, Inc.:企業のM&A・事業提携・投資動向
    CA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CA, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Kerecis ehf:医療機器:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Pitney Bowes Inc.:企業の戦略・SWOT・財務情報
    Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report Summary Pitney Bowes Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • AEI Services LLC-エネルギー分野:企業M&A・提携分析
    Summary AEI Services LLC (AEI), formerly Ashmore Energy International, is an energy utility company that owns, develops and operates power generation assets. The company also carries out the natural gas transportation and distribution businesses in emerging markets. Its power generation portfolio co …
  • Sotera Health LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Donaldson Company, Inc.:企業の戦略・SWOT・財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ranhill Holdings Berhad (RANHILL):企業の財務・戦略的SWOT分析
    Ranhill Holdings Berhad (RANHILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • RWE AG:企業の戦略・SWOT・財務情報
    RWE AG - Strategy, SWOT and Corporate Finance Report Summary RWE AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Vectra Bank Colorado:企業の戦略・SWOT・財務情報
    Vectra Bank Colorado - Strategy, SWOT and Corporate Finance Report Summary Vectra Bank Colorado - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NOJA Power Switchgear Pty Ltd:企業の戦略的SWOT分析
    NOJA Power Switchgear Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Atlas Copco AB (ATCO A):石油・ガス:M&Aディール及び事業提携情報
    Summary Atlas Copco AB (Atlas Copco) is a provider of industrial productivity solutions. It develops and manufactures vacuum solutions, air treatment systems, compressors, assembly systems, construction and mining equipment, and power tools. The company’s products include vacuum solutions and air tr …
  • Infant Bacterial Therapeutics AB (IBT B):製薬・医療:M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Operation Technology Inc:企業の戦略的SWOT分析
    Operation Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PromptCare Inc-製薬・医療分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆